Status:

NOT_YET_RECRUITING

A Pragmatic Randomized Controlled Trial: The Efficacy and Safety of Shoulder MSAT on in Patients With Shoulder Pain

Lead Sponsor:

Jaseng Medical Foundation

Conditions:

Shoulder Pain

Eligibility:

All Genders

19-70 years

Phase:

NA

Brief Summary

This study will test the effectiveness and safety of Motion Style Acupuncture Treatment (MSAT) for shoulder pain caused by traffic accidents. About 98 hospitalized patients with acute shoulder pain af...

Detailed Description

This pragmatic randomized controlled trial is designed to evaluate the efficacy and safety of Motion Style Acupuncture Treatment (MSAT) for acute shoulder pain resulting from traffic accidents. Should...

Eligibility Criteria

Inclusion

  • Adults aged 19 to 70 years
  • Hospitalized with shoulder pain within 5 days after a traffic accident
  • Shoulder pain intensity ≥ 5 on the Numeric Rating Scale (NRS) with observed limitation of movement
  • Able and willing to provide written informed consent

Exclusion

  • Serious conditions causing shoulder pain (e.g., malignant tumor, infection)
  • Progressive or severe neurological deficits
  • Recent shoulder surgery or procedure within 3 weeks
  • Shoulder pain mainly due to non-shoulder disorders (e.g., fibromyalgia, rheumatoid arthritis, gout)
  • Contraindications to MSAT (e.g., fracture, dislocation, ligament rupture or instability, severe inflammation)
  • Chronic diseases interfering with assessment (e.g., cardiovascular disease, renal disease, diabetic neuropathy, dementia, epilepsy)
  • Current use of steroids, immunosuppressants, psychiatric drugs, or other medications that may affect results
  • Contraindications to acupuncture (e.g., bleeding disorders, anticoagulant use, severe diabetes, severe cardiovascular disease)
  • Pregnant or planning pregnancy
  • Severe psychiatric illness
  • Participation in another interventional clinical trial
  • Unable to provide informed consent
  • Any other condition deemed inappropriate by the investigator

Key Trial Info

Start Date :

October 30 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2026

Estimated Enrollment :

98 Patients enrolled

Trial Details

Trial ID

NCT07187336

Start Date

October 30 2025

End Date

December 31 2026

Last Update

September 23 2025

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.